A comparative study of carbonic anhydrase activity in lymphocytes from colorectal cancer tissues and adjacent healthy counterparts.
Carbonic anhydrase
T cells
colorectal cancer
isoforms
tumour-infiltrating lymphocyte
Journal
Journal of enzyme inhibition and medicinal chemistry
ISSN: 1475-6374
Titre abrégé: J Enzyme Inhib Med Chem
Pays: England
ID NLM: 101150203
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
entrez:
13
6
2022
pubmed:
14
6
2022
medline:
15
6
2022
Statut:
ppublish
Résumé
Several carbonic anhydrase (CA, EC 4.2.1.1) isoforms play an essential role in processes connected to tumorigenesis, as they efficiently accelerate the hydration of carbon dioxide to bicarbonate and proton. In this context, examples are CA IX and CA XII, which were proved to be upregulated in many solid malignancies. On the other hand, cancer and the immune system are inextricably linked, and targeting the immune checkpoints recently was shown to efficiently improve the treatment of malignancies. In this study, we have investigated the expression of CA isoforms in tumour-infiltrating lymphocytes (TILs) that, according to the immunosurveillance theory, were suggested to have a crucial role in the development of colorectal cancer (CRC). T lymphocytes isolated from healthy surrounding mucosa showed a higher CA activity compared to those present in tumour and peripheral blood in the same patients. CA I and II were confirmed as enzyme isoforms involved in the process, as determined by proteomic analysis of corresponding TIL samples. These preliminary findings suggest a dysregulation of the local immune response in the CRC tissues and a loss of effective anticancer mechanisms mediated by CAs therein.
Identifiants
pubmed: 35695123
doi: 10.1080/14756366.2022.2085694
pmc: PMC9225793
doi:
Substances chimiques
Antigens, Neoplasm
0
Carbonic Anhydrase Inhibitors
0
Carbonic Anhydrase IX
EC 4.2.1.1
Carbonic Anhydrases
EC 4.2.1.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1651-1655Références
Front Immunol. 2017 Dec 22;8:1900
pubmed: 29375559
J Enzyme Inhib Med Chem. 2015 Apr;30(2):277-82
pubmed: 25007132
Int J Mol Sci. 2020 Nov 19;21(22):
pubmed: 33228233
ChemMedChem. 2016 Sep 6;11(17):1904-14
pubmed: 27304878
Signal Transduct Target Ther. 2020 Mar 20;5(1):22
pubmed: 32296018
Cell. 2017 May 4;169(4):750-765.e17
pubmed: 28475900
Lancet Oncol. 2017 Sep;18(9):1182-1191
pubmed: 28734759
BJU Int. 2013 Jun;111(7):1046-53
pubmed: 23551810
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Enzyme Inhib Med Chem. 2015 Apr;30(2):325-32
pubmed: 24766661
Eur J Immunol. 2018 Sep;48(9):1456-1469
pubmed: 29999523
Metabolites. 2017 Nov 11;7(4):
pubmed: 29137134
Front Immunol. 2019 Nov 26;10:2708
pubmed: 31849937
Ann Oncol. 2018 Jan 1;29(1):44-70
pubmed: 29155929
Genes Dev. 2018 Oct 1;32(19-20):1267-1284
pubmed: 30275043
World J Gastroenterol. 2016 Sep 28;22(36):8168-77
pubmed: 27688658
Proc R Soc Med. 1975 Aug;68(8):511-3
pubmed: 682
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Curr Top Med Chem. 2016;16(21):2359-68
pubmed: 27072694
Am J Physiol Renal Physiol. 2014 Oct 1;307(7):F869-80
pubmed: 25143453
Front Immunol. 2021 Mar 25;12:643441
pubmed: 33841426
Int J Oncol. 2013 Aug;43(2):611-21
pubmed: 23727877
Front Immunol. 2021 Jan 08;11:573158
pubmed: 33488574
Bioorg Med Chem. 2016 Mar 1;24(5):1115-20
pubmed: 26850377
Cancer Immunol Immunother. 2013 Jul;62(7):1249-60
pubmed: 23640603
Am J Pathol. 1994 Sep;145(3):598-609
pubmed: 8080042
Cancer Res. 2009 Jan 1;69(1):358-68
pubmed: 19118021
Nat Commun. 2017 Oct 6;8(1):797
pubmed: 28986522
Curr Opin Genet Dev. 2010 Feb;20(1):51-6
pubmed: 19942427
J Enzyme Inhib Med Chem. 2016;31(sup4):54-59
pubmed: 27615265
Front Immunol. 2020 Sep 18;11:1624
pubmed: 33042104
Gastroenterology. 1997 Feb;112(2):398-408
pubmed: 9024293
Nat Med. 2013 May;19(5):619-25
pubmed: 23584089
J Physiol. 2006 Mar 1;571(Pt 2):319-27
pubmed: 16396925
Br J Cancer. 2019 Nov;121(10):809-818
pubmed: 31607751
Physiol Rev. 2022 Jul 1;102(3):1327-1383
pubmed: 35166161
J Biol Chem. 2004 Jun 11;279(24):25374-80
pubmed: 15054097
J Cell Physiol. 2012 Dec;227(12):3887-94
pubmed: 22552906
Nat Rev Cancer. 2019 Mar;19(3):133-150
pubmed: 30755690
Cancer Immunol Immunother. 2009 Nov;58(11):1819-30
pubmed: 19319530
Mol Cell Proteomics. 2016 Mar;15(3):1007-16
pubmed: 26637539
J Enzyme Inhib Med Chem. 2016 Oct;31(5):689-94
pubmed: 26118417